Shared and separate functions of polo-like kinases and aurora kinases in cancer
The DOI matches its Crossref record; 228 of the 228 references it cites were found in a registry or an index.
Abstract
Large numbers of inhibitors for polo-like kinases and aurora kinases are currently being evaluated as anticancer drugs. Interest in these drugs is fuelled by the idea that these kinases have unique functions in mitosis. Within the polo-like kinase family, the emphasis for targeted therapies has been on polo-like kinase 1 (PLK1), and in the aurora kinase family drugs have been developed to specifically target aurora kinase A (AURKA; also known as STK6) and/or aurora kinase B (AURKB; also known as STK12). Information on the selectivity of these compounds in vivo is limited, but it is likely that off-target effects within the same kinase families will affect efficacy and toxicity profiles. In addition, it is becoming clear that interplay between polo-like kinases and aurora kinases is much more extensive than initially anticipated, and that both kinase families are important factors in the response to classical chemotherapeutics that damage the genome or the mitotic spindle. In this Review we discuss the implications of these novel insights on the clinical applicability of polo-like kinase and aurora kinase inhibitors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, some kinases and phosphatases simultaneously hit the same kinesins to tune the balance between phosphorylation and dephosphorylation to modulate activity or spindle targeting [56, 57].”
From Regulatory mechanisms that control mitotic kinesins (2015) · cites this paper as [56]
Citations
Cites
Microtubules as a target for anticancer drugs
Jordan, M. A., & Wilson, L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1317 · Cited by 4,000 · cited 1×
“Well-known examples of these drugs are those that perturb the formation of the mitotic spindle such as taxanes and vinca alkaloids”
BackgroundEffects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. B. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 2,967 · cited 1×
“This means that their mode of action will be different from inhibitors of the ERBB2 (also known as HER2 or neu receptor) or the breakpoint cluster region (BCR)–ABL1 oncoproteins that directly suppress oncogenic signal”
BackgroundAddiction to Oncogenes--the Achilles Heal of Cancer
Weinstein, I. B. (2002) · Science · doi:10.1126/science.1073096 · Cited by 1,728
The anaphase promoting complex/cyclosome: a machine designed to destroy
Peters, J.-M. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1988 · Cited by 1,315 · cited 1×
“Once proper chromosome alignment is established, cyclin B and securin are degraded by the anaphase-promoting complex/cyclosome bound to CDC20 (APC/C CDC20”
BackgroundTyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene Products
Lugo, T. G., Pendergast, A.-M., Muller, A. J., & Witte, O. N. (1990) · Science · doi:10.1126/science.2408149 · Cited by 1,281 · cited 1×
“This means that their mode of action will be different from inhibitors of the ERBB2 (also known as HER2 or neu receptor) or the breakpoint cluster region (BCR)–ABL1 oncoproteins that directly suppress oncogenic signal”
BackgroundTumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation
Zhou, H., Kuang, J., Zhong, L., Kuo, W.-L., Gray, J., Sahin, A., Brinkley, B., & Sen, S. (1998) · Nature Genetics · doi:10.1038/2496 · Cited by 1,276
A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers
Bischoff, J. R. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3052 · Cited by 1,216 · cited 1×
“Oncogenic activity Overexpression of aurora kinase A induces oncogenic transformation in immortalized rodent fibroblast”
BackgroundDitchfield, C., Johnson, V. L., Tighe, A., Ellston, R., Haworth, C., Johnson, T., Mortlock, A., Keen, N., & Taylor, S. S. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200208091 · Cited by 1,194 · cited 1×
“gov/drugdictionary/?CdrID=39762">paclitaxel (also known as Taxol)-induced mitotic arres”
BackgroundHauf, S., Cole, R. W., LaTerra, S., Zimmer, C., Schnapp, G., Walter, R., Heckel, A., van Meel, J., Rieder, C. L., & Peters, J.-M. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200208092 · Cited by 1,155 · cited 1×
“gov/drugdictionary/?CdrID=39762">paclitaxel (also known as Taxol)-induced mitotic arres”
BackgroundA Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene
Luo, J., Emanuele, M. J., Li, D., Creighton, C. J., Schlabach, M. R., Westbrook, T. F., Wong, K.-K., & Elledge, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.05.006 · Cited by 1,017 · cited 1×
“Most recently, tumour cell lines carrying a KRAS-G13D mutation were shown to be hypersensitive to inhibition of PLK1 (Ref”
Background
Cited by
Items 401–500 of 609
Herz, C., Schluermann, F., Batarello, D., Fichter, C. D., Schöpflin, A., Münch, C., Hauschke, D., Werner, M., & Laßmann, S. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20823 · Cited by 12
Working hard for recovery: mitotic kinases in the DNA damage checkpoint
Peng, A. (2013) · Cell & Bioscience · doi:10.1186/2045-3701-3-20 · Cited by 16
“Readers are referred to several excellent reviews for detailed functions and regulatory mechanisms of these mitotic kinases [3,4,10-17].”
InfluentialCircular RNAs as diagnostic biomarker in pancreatic cancer
Fathizadeh, H., Hallajzadeh, J., & Asemi, Z. (2020) · Pathology - Research and Practice · doi:10.1016/j.prp.2020.153075 · Cited by 12
Mancini, M., Leo, E., Aluigi, M., Marcozzi, C., Borsi, E., Barbieri, E., & Santucci, M. A. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.03.025 · Cited by 12
“[8] Lens SMA, Voest EE, Medema RH.”
BackgroundInfluentialOu, S., Tan, M.-H., Weng, T., Li, H., & Koh, C.-G. (2018) · Open Biology · doi:10.1098/rsob.170202 · Cited by 12
“The membranes were blocked with 5% BSA and probed with one of the following antibodies: mouse monoclonal anti-actin (1 : 5000; Chemicon International), rabbit polyclonal anti-AurkA (1 : 1000; Abcam), mouse monoclonal anti-GAPDH (1 : 5000; Ambion), rabbit polyclonal antiLIMK1 (1 : 1000; Cell Signaling Technology), rabb…”
BackgroundInfluentialThe role of Aurora-A kinase in the Golgi-dependent control of mitotic entry
Cervigni, R. I., Barretta, M. L., Persico, A., Corda, D., & Colanzi, A. (2011) · BioArchitecture · doi:10.4161/bioa.1.2.15329 · Cited by 12
Akter, M. S., Uddin, M. H., Rahman, S. A., Hossain, M. A., Ashik, M. A. R., Zaman, N. N., Faruk, O., Hossain, M. S., Parvin, A., & Rahman, M. H. (2024) · Cancer Reports · doi:10.1002/cnr2.2009 · Cited by 14
Ning, B., Liu, C., Kucukdagli, A. C., Zhang, J., Jing, H., Zhou, Z., Zhang, Y., Dong, Y., Chen, Y., Guo, H., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-87315-x · Cited by 11
Ke, Y., Chang, C., Lin, W., Tsai, C., Chiu, I., Wang, W.-P., Wang, P., Chen, P., Lin, W., Chang, C.-F., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.03.064 · Cited by 11
Kudo, M., Zalles, N., Distefano, R., Nigita, G., Veneziano, D., Gasparini, P., & Croce, C. M. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00864-2 · Cited by 13
“In silico analysis of miR-183-5p/PLK1 anticorrelation PLK1 overexpression is present in various malignancies and has been considered a diagnostic as well as prognostic marker [8, 14, 38, 39].”
BackgroundYan, Z., Shi, Q., Liu, X., Li, J., Ahire, V. R., Zhang, S., Zhang, J., Yang, D., & Allen, T. D. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112645 · Cited by 11
Dibb, M. J., Han, N., Choudhury, J., Hayes, S. J., Valentine, H. R., West, C., Sharrocks, A. D., & Ang, Y. S. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1658-y · Cited by 11
Alférez, D., Goodlad, R. A., Odedra, R., Sini, P., Crafter, C., Ryan, A. J., Wedge, S. R., WRIGHT, N. A., Anderson, E., & Wilkinson, R. W. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1580 · Cited by 11
Antitumor activity of AZ64 via G2/M arrest in non-small cell lung cancer
Xue, Y., Ren, H., Xiao, W. L., Chu, Z., LEE, J. J., & Mao, L. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1619 · Cited by 11
Nilsson, E. M., Brokken, L. J. S., Narvi, E., Kallio, M. J., & Härkönen, P. L. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.03.009 · Cited by 11
“chromatid resolution, chromosome-spindle connections and cytokinesis (reviewed in (Lens et al., 2010)).”
BackgroundWarren, N. J. H., Donahue, K. L., & Eastman, A. R. (2019) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00001 · Cited by 10
Fernández-Sainz, J., Pacheco-Liñán, P. J., Granadino‐Roldán, J. M., Bravo, I., Rubio, J., Albaladejo, J., & Garzón‐Ruiz, A. (2022) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2022.112477 · Cited by 10
“PLK1 is therefore essential for regulating the cell division and maintaining genome stability during mitosis, spindle assembly and DNA damage response [5,11].”
BackgroundAccattatis, F. M., Caruso, A., Carleo, A., Console, P. D., Gelsomino, L., Bonofiglio, D., Giordano, C., Barone, I., Andò, S., Bianchi, L., et al. (2023) · Nutrients · doi:10.3390/nu15132839 · Cited by 11
“PLK1 is also required for genome stability preservation and DNA damage response [149,154].”
BackgroundYang, C., Plum, P. S., Gockel, I., & Thieme, R. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1186101 · Cited by 11
“AURKA has recently garnered attention for its atypical expression in various human tumors (3 – 7), suggesting its potential as a vital biomarker for diagnosing and predicting the prognosis of diverse cancers.”
BackgroundGoos, J. A. C. M., Verbeek, J., Geldof, A. A., Hiemstra, A. C., van de Wiel, M. A., Adamzek, K., Diemen, P. M. D., Stroud, S. G., Bradley, D. P., Meijer, G. A., et al. (2015) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2015.08.007 · Cited by 10
“In phase I and II clinical studies, treatment with alisertib generally showed good (partial) response rates (4%– 52%), depending on origin of the tumor [6,10,13–16].”
BackgroundChan, C., Lan, R., Tsang, M., Zhou, D., Lear, S., Chan, W., Cobb, S. L., Wong, W., Hao, J., Wong, W., et al. (2015) · Journal of Materials Chemistry B · doi:10.1039/c4tb02104e · Cited by 10
Thaiparambil, J. T., Mansour, O. C., & El‐Zein, R. A. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx229 · Cited by 11
“Among them, Aurora kinases play a prominent role as essential regulators of the mitotic spindle (Lens et al., 2010; Vader et al., 2008).”
BackgroundNecroptosis Related Genes Predict Prognosis and Therapeutic Potential in Gastric Cancer
Wu, N., Liu, F., Huang, Y., Su, X., Zhang, Y., Yu, L., & Liu, B. (2023) · Biomolecules · doi:10.3390/biom13010101 · Cited by 11
“PLK1 was extensively studied to examine its function in cell cycle regulation [42], and it was involved in the development of various cancers [43].”
BackgroundSpänkuch, B., Keppner, S., Lange, L. D., Rodrigues, T., Zettl, H., Koch, C. P., Reutlinger, M., Hartenfeller, M., Schneider, P., & Schneider, G. (2012) · Angewandte Chemie · doi:10.1002/ange.201206897 · Cited by 9
Yu, C., Liu, S., Hsu, J., Hsu, J. T., Kudryavtsev, K. V., & Guh, J. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-014-0107-x · Cited by 11
“Several cellular stresses, including disturbance of microtubule dynamics and inhibition of Aurora A during mitosis, have been suggested to induce mitotic arrest of the cell cycle [28,29].”
Burgess, E. F., Livasy, C., Trufan, S. J., Hartman, A. L., Guerreri, R., Naso, C., Clark, P. E., Grigg, C. M., Symanowski, J. T., & Raghavan, D. (2019) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2019.09.009 · Cited by 9
Liu, A.-B., Liu, J., Wang, S., Ма, Л., & Zhang, J. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03355-9 · Cited by 10
“PLK1 is involved in the regulation of entry into mitosis and the G2/M checkpoint [51, 52].”
BackgroundRadiosensitization in esophageal squamous cell carcinoma
Chen, J. L., Chen, J., Huang, Y., Tsai, Y.-C., Tsai, M.-H., Jaw, F., Cheng, J. C., Kuo, S., & Shieh, M. (2016) · Strahlentherapie und Onkologie · doi:10.1007/s00066-016-0951-6 · Cited by 9
“Irradiation has been demonstrated to result in unrepaired DNA damage and subsequent mitotic catastrophe, raising the possibility that irradiation combined with mitosis inhibitor would be potentially efficient in inducing tumor cell death [22].”
BackgroundDrug design and molecular docking simulations of Polo-like kinase 1 inhibitors based on QSAR study
Tong, J., Wang, T., & Feng, Y. (2020) · New Journal of Chemistry · doi:10.1039/d0nj04367b · Cited by 9
Genetic variations in AURORA cell cycle kinases are associated with glioblastoma multiforme
Mešić, A., Rogar, M., Hudler, P., Bilalović, N., Eminović, I., & Komel, R. (2021) · Scientific Reports · doi:10.1038/s41598-021-96935-y · Cited by 9
Quan, M., Oh, Y., Cho, S., Kim, J. H., & Moon, H. (2022) · Journal of Breast Cancer · doi:10.4048/jbc.2022.25.e28 · Cited by 11
“Genetic ablation of PLK1 or its chemical inhibition induces G2/M arrest, creates multipolar cell division, and eventually induces apoptotic cell death [31,32].”
BackgroundPLK1 as one novel target for the poor prognosis of bladder cancer: An observational study
Liu, B., Meng, L., Su, J., Fan, B., Zhao, S., Wang, H., Li, T., Wang, T.-Y., Zhang, A., & Ni, X. (2022) · Medicine · doi:10.1097/md.0000000000030723 · Cited by 9
“PLK1 is critical for precisely regulating cell division and maintaining genomic stability in mitosis, spindle assembly, and DNA damage responses.[14] Studies have found that it is highly expressed in prostate cancer,[15] neuroblastoma cells,[16] acute myeloid leukemia,[17] cervical cancer,[18] and other malignant tumo…”
BackgroundVuong, M.-C. T., Hasegawa, L. S., & Eastmond, D. A. (2012) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2012.09.005 · Cited by 9
Mercado-Pimentel, M. E., Igarashi, S., Dunn, A. M., Behbahani, M. N., Miller, C., Read, C. M., & Jacob, A. (2016) · PubMed · Cited by 9
Developing Polo-like Kinase 1 Inhibitors
Huang, X., Xie, Z., & Liao, C. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2020-0055 · Cited by 9
Dueñas, M., Santos, M., Aranda, J. F., Bielza, C., Martínez‐Cruz, A. B., Lorz, C., Tarón, M., Ciruelos, E., Rodríguez‐Peralto, J. L., Martín, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042494 · Cited by 10
Tamaki, S., Suzuki, K., Abe, I., Endo, Y., Kakizawa, N., Watanabe, F., Saito, M., Tsujinaka, S., Miyakura, Y., Ohta, S., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-15071-3 · Cited by 10
An immune‐related gene signature for the prognosis of human bladder cancer based on WGCNA
Cheng, J., Zhang, S., Fan, A., Li, Y., Xu, P., Huang, J., He, M., & Wang, H. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106186 · Cited by 9
IQGAP3 promotes the progression of glioma as an immune and prognostic marker
Gao, X., Ge, J., Gao, X., MEI, N., Su, Y., Shan, S., Qian, W., Guan, J., Zhang, Z., & Wang, L. (2024) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2023.046712 · Cited by 9
Cullin' PLK1 from kinetochores
McGourty, C. A., & Rapé, M. (2013) · Nature Cell Biology · doi:10.1038/ncb2722 · Cited by 8
Wang, K., Zhang, Y., Yang, X., Chen, T., & Han, T. (2020) · Translational Cancer Research · doi:10.21037/tcr-20-812 · Cited by 8
“PLK1 also acts as a mitotic switch to mediate repair after DNA damage, reducing genetic mutations caused by DNA damage (19).”
BackgroundChan, C., Xie, C., Tsang, M., Lear, S., Dai, L., Zhou, Y., Cicho, J., Karbowiak, M., Hreniak, D., Lan, R., et al. (2015) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.201500321 · Cited by 8
Koh, D., Jung, Y., Ahn, S., Mok, K. H., Shin, S. Y., & Lim, Y. (2017) · Magnetic Resonance in Chemistry · doi:10.1002/mrc.4611 · Cited by 8
Malumbres, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00004-9 · Cited by 16
Qian, Y., Li, Y., Chen, K., Liu, N., Hong, X., Wu, D., Xu, Z., Zhou, L., Xu, L., Jia, R., et al. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s347732 · Cited by 8
Monoclonal Antibodies Against Xenopus Greatwall Kinase
Wang, L., Fisher, L. A., Wahl, J. K., & Peng, A. (2011) · Hybridoma · doi:10.1089/hyb.2011.0051 · Cited by 8
“Importantly, some of these kinases, such as Plk1 and Aurora kinases, exhibit oncogenic characteristics and are potentially targetable for cancer therapy.((2)) Greatwall (Gwl), initially identified in Drosophila as a protein required for proper chromosome condensation and mitotic progression,((3)) has been extensively…”
Mancini, M., De Santis, S., Monaldi, C., Castagnetti, F., Lonetti, A., Bruno, S., Dan, E., Sinigaglia, B., Rosti, G., Cavo, M., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.901132 · Cited by 7
“Chronic myeloid leukemia (CML) is characterized by the Philadelphia (Ph) chromosome resulting from the t(9;22)(q34; q11) translocation that generates the BCR::ABL1 oncogene.”
BackgroundWang, T., Wang, S., Li, Z., Xie, J., Chen, H., & Hou, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1485123 · Cited by 9
Cunningham, C. E., Vizeacoumar, F. S., Zhang, Y., Kyrylenko, L., Both, S., Maranda, V., Dong, H., Price, J. D. W., Gao, P., Wagner, K., et al. (2025) · Cell Genomics · doi:10.1016/j.xgen.2025.100876 · Cited by 11
BORA regulates cell proliferation and migration in bladder cancer
Cheng, S., Peng, T., Zhu, X., Zhou, F., Wang, G., Ju, L., Xiao, Y., Liu, X., & Wang, X. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01392-8 · Cited by 7
Bucko, P. J., Garcia, I., Manocha, R., Bhat, A., Wordeman, L. G., & Scott, J. D. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014791 · Cited by 7
Mancini, M., Monaldi, C., Santis, S. D., Papayannidis, C., Rondoni, M., Sartor, C., Bruno, S., Pagano, L., Criscuolo, M., Zanotti, R., et al. (2023) · Biomarker Research · doi:10.1186/s40364-023-00468-7 · Cited by 8
Oduro‐Kwateng, E., Rabbad, A. H., & Soliman, M. E. S. (2023) · Journal of Computational Biophysics and Chemistry · doi:10.1142/s2737416523500680 · Cited by 7
Zhu, W., Gui, X., Zhou, Y., Gao, X., Zhang, R., Li, Q., Zhang, H., Zhao, J., Cui, X., Gao, G., et al. (2023) · Experimental Eye Research · doi:10.1016/j.exer.2023.109753 · Cited by 7
Drugging RB1 Deficiency: Synthetic Lethality with Aurora Kinases
Dick, F. A., & Li, S. S. ‐. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1448 · Cited by 7
“Aurora kinases also contribute to cell-cycle progression and mitotic fidelity through centrosomes, mitotic spindle formation, and chromosome attachment and separation (8).”
BackgroundFard, S. S., Sotoudeh, M., Yazdanbod, M., Ghavamzadeh, A., Malekzadeh, R., Yaghmaie, M., Mousavi, S. A., Ghaffari, S. H., & Alimoghaddam, K. (2019) · International Journal of Hematology-Oncology and Stem Cell Research · doi:10.18502/ijhoscr.v13i4.1891 · Cited by 7
Huang, J., Wen, F., Huang, W., Bai, Y., Lu, X., & Shu, P. (2020) · Biomarkers in Medicine · doi:10.2217/bmm-2019-0608 · Cited by 7
The Relevance of Aurora Kinase Inhibition in Hematological Malignancies
Machado, C. B., da Silva, E. L., Nogueira, B. M. D., da Silva, J. B. S., de Moraes, M. O., Montenegro, R. C., de Moraes, M. E. A., & Moreira-Nunes, C. A. (2021) · Cancer Diagnosis & Prognosis · doi:10.21873/cdp.10016 · Cited by 8
“Besides its role in cellular spatial organization, AURKA also exerts a series of nuclear functions related to the control of mitotic checkpoint G 2 /M (Figure 2), making it a key factor in initiation of mitosis (20, 29).”
BackgroundGórecki, L., Muthná, D., Merdita, S., Andrš, M., Kucera, T., Havelek, R., Múčková, Ľ., Kobrlová, T., Soukup, J., Krůpa, P., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114580 · Cited by 7
Salmela, A.-L., Pouwels, J., Mäki-Jouppila, J. H., Kohonen, P. J., Toivonen, P., Kallio, L., & Kallio, M. J. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs339 · Cited by 7
Espinosa, A. M., Alfaro, A., Román-Basaure, E., Guardado-Estrada, M., Lara, I. P., Serralde, C., Medina, I., Juárez, E., BermÃodez, M., Márquez, E., et al. (2013) · PLoS ONE · doi:10.1371/annotation/36613e7a-41fa-4199-87eb-40214100b4cb · Cited by 7
The Anaphase-Promoting Complex/Cyclosome Is a Cellular Ageing Regulator
Hu, X., Jin, X., Cao, X., & Liu, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315327 · Cited by 8
Polo-like kinase inhibitors increase AAV production by halting cell cycle progression
Fisher, K., Grafton, F., Ispaso, F., Tworig, J. M., Derler, R., Sonntag, F., Hörer, M., Schulze, A., Reid, C. A., & Mandegar, M. A. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101412 · Cited by 8
Mukherjee, A., Manna, S., Singh, A. K., Ray, A., & Srivastava, S. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00885 · Cited by 8
Designed inhibitor for nuclear localization signal of polo‐like kinase 1 induces mitotic arrest
Chen, F., Zhuo, X., Tan, Q., Guo, X., Zhang, C., & Lai, L. (2016) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12896 · Cited by 6
Vadlakonda, R., Nerella, R., & Enaganti, S. (2016) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-016-0205-4 · Cited by 6
Ghosh, G., Misra, S., Ray, R., Chowdhury, S. G., & Karmakar, P. (2023) · Medical Oncology · doi:10.1007/s12032-023-01985-z · Cited by 6
“Overactivation of these mitotic kinases results in unregulated chromosomal segregation and mitotic pole disintegration [45].”
BackgroundA growing role for Aurora A in chromosome instability
Maia, A. R. R., van Heesbeen, R. G. H. P., & Medema, R. H. (2014) · Nature Cell Biology · doi:10.1038/ncb3018 · Cited by 6
Self-citationHsieh, Y., Liu, T., & Yang, P. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.03.002 · Cited by 6
Mešić, A., Rogar, M., Hudler, P., Bilalović, N., Eminović, I., & Komel, R. (2019) · BMC Cancer · doi:10.1186/s12885-019-6133-z · Cited by 7
Liu, J., Ma, L., Chen, Z., Song, Y., Gu, T., Liu, X., Zhao, H., & Yao, N. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-4427 · Cited by 6
“been investigated more intensively than the other four PLKs (20,21).”
BackgroundInfluentialPan, Y., Lai, J. C., Huang, W., Peng, P., Jung, S., Lin, S., Chen, C., Wu, C., Hung, T., Yu, A. L.-T., et al. (2023) · Cancer Gene Therapy · doi:10.1038/s41417-023-00705-z · Cited by 9
“For the regulation of AJs, dimerization of E-cadherin is modulated by the inside-out regulation of several proteins and factors, such as vinculin, cytoskeleton organization, and cytoskeletal tension [56].”
A Systems Biology Approach to Personalizing Therapeutic Combinations
Kwong, L. N., Heffernan, T. P., & Chin, L. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0394 · Cited by 7
Rizvi, S. M. D., Alshammari, A. A. A., Almawkaa, W. A., Ahmed, A. B. F., Katamesh, A. A., Alafnan, A. D., Almutairi, T. J., & Alshammari, R. F. (2019) · 3 Biotech · doi:10.1007/s13205-019-1594-y · Cited by 6
Cell Proliferation and Differentiation
Watanabe, N., & Osada, H. (2017) · Springer eBooks · doi:10.1007/978-4-431-56529-1_2 · Cited by 7
DDIAS shields single-stranded DNA in mitosis and promotes vertebrate brain development
Tsukada, K., Lototska, L., 塚田, 絢., Sarusie, M. V., Gönenç, I. I., Sherlaw‐Sturrock, C., Kanade, M., Palek, M., Oliver, A. W., Jones, S. E., et al. (2026) · Cell · doi:10.1016/j.cell.2026.07.041 · Cited by 6
Knowledge mapping of AURKA in Oncology:An advanced Bibliometric analysis (1998–2023)
Qiong, Z., Tao, C., Yuan, J., Pan, F., & Wang, R. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e31945 · Cited by 5
“…cellular processes, such as centrosome maturation regulation, spindle assembly checkpoint signaling, DNA damage response, and cell migration [10,11] The abnormal expression or activity of AURKA has been detected across various types of cancer, including breast, lung, colorectal, pancreatic,…”
BackgroundGyulavári, P., Szokol, B., Szabadkai, I., Brauswetter, D., Bánhegyi, P., Varga, A., Markó, P., Boros, S., Illyés, E., Szántai-Kis, C., et al. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.05.064 · Cited by 5
Huang, C., Chen, L., Zhang, Y., Wang, L., Zheng, W., Peng, F., & Xu, Y. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.926546 · Cited by 5
“Upregulation of AURKA has been reported in various cancers, including neuroblastoma, lymphoma, colorectal, ovarian and prostate cancers (Lens et al., 2010; Willems et al., 2018).”
BackgroundA novel glycolysis-related gene signature for predicting the prognosis of multiple myeloma
Zhang, B., Wang, Q., Lin, Z., Zheng, Z., Zhou, S., Zhang, T., Zheng, D., Chen, Z., Zheng, S., Zhang, Y., et al. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1198949 · Cited by 7
“Overexpression of AURKA has been linked to oncogenic transformation, including chromosomal instability and disruption of multiple oncoprotein regulatory pathways and tumor suppressors (Zhou et al., 1998; Lens et al., 2010; Nikonova et al., 2013).”
BackgroundTanaka, S. (2018) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12059 · Cited by 5
“Aurora kinases are serine/threonine kinases that play major roles in chromosomal alignment and segregation during mitosis and cytokinesis.(25) Aurora A localizes to the spindle poles, whereas Aurora B localizes to the midbody of the central spindle during mitosis.”
BackgroundLian, A. T., & Chircop, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.30064-5 · Cited by 7
The cAMP-PKA signaling initiates mitosis by phosphorylating Bora
Zhu, M., Zhou, S., Zhang, Y., Chen, Q., Yuan, X., Zhang, L., Yan, H., & Wang, F. (2025) · Nature Communications · doi:10.1038/s41467-025-63352-y · Cited by 4
Aurora-B: a novel biomarker in the invasion and metastasis of osteosarcoma
Long, S., Zhong, Y., & Liu, J. (2024) · Biomarkers in Medicine · doi:10.1080/17520363.2024.2366160 · Cited by 4
Schneider, V., Egenrieder, S., Götz, M., Herbst, C., Greiner, J., & Hofmann, S. (2012) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2012.740667 · Cited by 4
Mechanisms of Cetuximab Resistance and How to Overcome It
Pauw, I. D., Boeckx, C., & Wouters, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-63234-2_3 · Cited by 4
Zhu, D., Zhang, H., Li, J., Qian, X., Meng, G., Jiang, G., & Gu, Y. (2022) · Advanced Therapeutics · doi:10.1002/adtp.202200087 · Cited by 5
Li, H., Tang, X., Sun, Z., Qu, Z., & Zou, X. (2023) · Biomolecules and Biomedicine · doi:10.17305/bb.2023.9665 · Cited by 7
“Super-numerary centrosomes arise from deregulation of the centrosome cycle, leading to multipolar mitosis, this in turn promotes genomic instability and mitotic catastrophe [51, 52].”
BackgroundA novel L-shaped ortho-quinone analog as PLK1 inhibitor blocks prostate cancer cells in G2 phase
Zhang, S., Yu, J. H., Tan, X., Cheng, S., Liu, H., Li, Z., Wei, S., Pan, W., & Luo, H. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115960 · Cited by 4
Role of PLK1 signaling pathway genes in gastrointestinal stromal tumors
Chen, J., Yeh, C., Cheng, C., Yen, C., Chen, Y., Huang, S., Chiang, K., Yeh, T., Chen, S., Chao, T., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.9003 · Cited by 4
“AURKA and PLK1 are involved in cytokinesis (19,20).”
InfluentialMalumbres, M. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00004-7 · Cited by 6
Centrosome Abnormality and Human Lung Cancer
Shinmura, K., & Sugimur, H. (2012) · InTech eBooks · doi:10.5772/26098 · Cited by 4
“PLK1 belongs to the mammalian PLK family, which is comprised of five members (PLK1 - PLK4 and PLK5P) (Lens et al., 2010).”
BackgroundTargeting hepatocarcinogenesis model in C56BL6 mice with pan-aurora kinase inhibitor Danusertib
Gavriilidis, P., Poutahidis, T., Giakoustidis, A. E., Makedou, K., Angelopoulou, K., Hardas, A., Andreani, P., Zacharioudaki, A., Saridis, G., Gargavanis, A. A., et al. (2018) · Journal of Cancer · doi:10.7150/jca.22329 · Cited by 4
“AURK plays a key role as essential regulators of the mitotic spindle and protein phosphorylation in mitotic control [27-29].”
BackgroundGenomic Instability and Cancer Metastasis
Gull, H., & Masood, N. (2020) · Springer eBooks · doi:10.1007/978-981-15-1067-0_6 · Cited by 5
Aurora Kinase A: Bridging Breast Cancer Therapy and Disability-Inclusive Care
Sen, A., Singh, P., Jangra, S., & Srivastava, P. (2025) · Springer eBooks · doi:10.1007/978-3-031-40858-8_469-1 · Cited by 4
Jayanthan, A., Hofmann, B., Meier‐Stephenson, V., Perinpanayagam, M. A., Dunn, S. E., Boklan, J., Trippett, T. M., Truong, T. H., & Narendran, A. (2019) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000001416 · Cited by 3
Wang, G., Dai, S., Gao, H., Gao, Y., Yin, L., Zhang, K., Huang, X., Lu, Z., & Miao, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.714718 · Cited by 5
Mancini, M., Monaldi, C., Santis, S. D., Rondoni, M., Papayannidis, C., Sartor, C., Curti, A., Bruno, S., Cavo, M., & Soverini, S. (2022) · Cancers · doi:10.3390/cancers14030738 · Cited by 3
High-resolution analysis of human centromeric chromatin
Melters, D. P., Bui, M., Rakshit, T., Grigoryev, S. A., Sturgill, D. M., & Dalal, Y. (2025) · Life Science Alliance · doi:10.26508/lsa.202402819 · Cited by 3
“Multipolar spindles are commonly formed because of centrosome defects (Lens et al, 2010).”
Modeling the mitotic regulatory network identifies highly efficient anti-cancer drug combinations
Wu, Y., Zhuo, X., Dai, Z., Guo, X., Wang, Y., Zhang, C., & Lai, L. (2014) · Molecular BioSystems · doi:10.1039/c4mb00610k · Cited by 4
Metadata
- Authors
- Lens, S. M. A., Voest, E. E., & Medema, R. H.
- Affiliations
- University Medical Center Utrecht (NL)
- Corresponding author
- Lens, Susanne M. A.
- Medema, René H.
- Venue
- Nature Reviews Cancer
- Published
- 2010-11-24
- Volume
- 10
- Issue
- 12
- Pages
- 825-841
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1994488152
- Cited by
- 597
- References
- 227
- Citations by year
- 2026: 17 · 2025: 25 · 2024: 10 · 2023: 28 · 2022: 24 · 2021: 29 · 2020: 42 · 2019: 37 · 2018: 27 · 2017: 33 · 2016: 36 · 2015: 56 · 2014: 59 · 2013: 64 · 2012: 65
- FWCI
- 4.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
- Keywords
- Polo-like kinase, Aurora kinases, PLK1, AURKA, Aurora B kinase, mitosis, kinase inhibitors, anticancer agents, off-target effects, chemosensitization, targeted therapy
- MeSH terms
- Polo-Like Kinase 1, Animals, Chromatids, Humans, Mitosis, Neoplasms, Proto-Oncogene Proteins, Protein Serine-Threonine Kinases, Kinetochores, Cell Cycle Proteins, Protein Kinase Inhibitors, Cytokinesis, Aurora Kinase A, Aurora Kinase B, Aurora Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.